The conference will aim to broaden the understanding of the ethical and regulatory frameworks, as well as defining the impact that the General Data Protection Regulation (GDPR) will have in 2018. The conference also aims at defining some amongst the most successful applications of biosamples in the market. Speakers are the result of a careful selection of experts in the industry and will include: directors of biorepositories, professionals working in regulatory agencies, drug discovery program directors and legal advisors.
Join us in June to take part in cutting-edge discussions through a series of interactive presentations, panel discussions and case-studies addressing all the critical issues regarding the improvement of Biobanking: a market that is expected to reach USD 2.69 Billion by 2022 from USD 1.85 Billion in 2017, at a CAGR of 7.8%.*